Suppr超能文献

组织型纤溶酶原激活剂给药后发生的高灌注综合征:一例有影像学证据的病例报告

Hyperperfusion Syndrome Following Tissue Plasminogen Activator Administration: A Case Report with Radiological Evidence.

作者信息

Koh Nam Hee, Kim Sam Soo, Oh Ha Yeun, Kim Seongheon, Jang Jae-Won

出版信息

J Korean Soc Radiol. 2024 Nov;85(6):1200-1208. doi: 10.3348/jksr.2024.0023. Epub 2024 Nov 21.

Abstract

Cerebral hyperperfusion syndrome is a rare complication that can occur following carotid artery revascularization procedures in patients with chronic carotid artery stenosis. Cases of hyperperfusion syndrome resulting solely from intravenous tissue plasminogen activator administration, without a history of revascularization, are extremely rare. Only four of such cases have been reported with imaging evidence. This report presents a case of early neurological deterioration in acute ischemic stroke, identified as a form of hyperperfusion syndrome. Imaging evidence supports this diagnosis, and highlights the occurrence of hyperperfusion syndrome after intravenous tissue plasminogen activator administration.

摘要

脑过度灌注综合征是一种罕见的并发症,可发生于慢性颈动脉狭窄患者的颈动脉血运重建术后。仅因静脉注射组织型纤溶酶原激活剂而导致的过度灌注综合征病例,且无血运重建史,极为罕见。仅有4例此类病例有影像学证据报道。本报告介绍了1例急性缺血性卒中早期神经功能恶化的病例,被确定为一种过度灌注综合征形式。影像学证据支持这一诊断,并突出了静脉注射组织型纤溶酶原激活剂后发生过度灌注综合征的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/11625835/1a728e2eab67/jksr-85-1200-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验